Treatments for Parkinsons

Treatments for Parkinsons

  Traditional Parkinson treatments in medicine involves the use of the amino acid levodopa with carbidopa and dopamine agonists. Problems include drugs that quit working and side effects. Typically, symptoms gradually gets worse over time. In 2001 NeuroResearch Clinics realized that virtually all the problems associated with standard Parkinson treatments stemmed from improper use of the levodopa and carbidopa. These problems can be categorized into four areas:

• levodopa side effects  due to being improperly balanced with serotonin nutrients.

• Depletion of serotonin by levodopa, during Treatments. When serotonin levels drop low enough the levodopa quits working and symptoms associated with serotonin depletion develop.

• Depletion of the sulfur amino acids by levodopa. This leads to depletion of glutathione causing more brain damage from neurotoxins, making the Treatments for Parkinsons worse. Depletion of sulfur amino acids causes depletion of adrenaline causing the patient to move very slow.

• Carbidopa depletes serotonin and dopamine peripherally causing numerous side effects.

  Parkinson treatment should not be with only levodopa with our without carbidopa.  Parkinson treatments should be with properly balanced levodopa, 5-HTP, tyrosine, cysteine guided by neurotransmitter testing as indicted. Use of of this combination of nutrient controls the side effect of nausea associated with levodopa and prevents the depletion of serotonin and glutathione in treatment. It also helps prevent progression of Parkinson Disease due to glutathione depletion which is needed to prevent further neurotoxic.

Treatments for Parkinsons

  Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine to treat medical patients in order to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.

The Peer Reviewed Research of NeuroResearch Clinics

  The neurotransmitter treatment research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD  President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression.